1. Home
  2. AVDL vs CMP Comparison

AVDL vs CMP Comparison

Compare AVDL & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • CMP
  • Stock Information
  • Founded
  • AVDL 2015
  • CMP 1993
  • Country
  • AVDL Ireland
  • CMP United States
  • Employees
  • AVDL N/A
  • CMP N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • AVDL Health Care
  • CMP Basic Materials
  • Exchange
  • AVDL Nasdaq
  • CMP Nasdaq
  • Market Cap
  • AVDL 861.4M
  • CMP 836.2M
  • IPO Year
  • AVDL 1996
  • CMP 2003
  • Fundamental
  • Price
  • AVDL $12.75
  • CMP $21.42
  • Analyst Decision
  • AVDL Strong Buy
  • CMP Buy
  • Analyst Count
  • AVDL 7
  • CMP 3
  • Target Price
  • AVDL $19.00
  • CMP $19.00
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • CMP 407.3K
  • Earning Date
  • AVDL 08-07-2025
  • CMP 08-11-2025
  • Dividend Yield
  • AVDL N/A
  • CMP N/A
  • EPS Growth
  • AVDL N/A
  • CMP N/A
  • EPS
  • AVDL N/A
  • CMP N/A
  • Revenue
  • AVDL $221,075,000.00
  • CMP $1,213,500,000.00
  • Revenue This Year
  • AVDL $56.78
  • CMP $11.60
  • Revenue Next Year
  • AVDL $30.46
  • CMP $2.33
  • P/E Ratio
  • AVDL N/A
  • CMP N/A
  • Revenue Growth
  • AVDL 132.35
  • CMP 5.81
  • 52 Week Low
  • AVDL $6.38
  • CMP $7.51
  • 52 Week High
  • AVDL $17.30
  • CMP $22.69
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 76.98
  • CMP 59.66
  • Support Level
  • AVDL $10.79
  • CMP $19.25
  • Resistance Level
  • AVDL $14.23
  • CMP $20.28
  • Average True Range (ATR)
  • AVDL 0.59
  • CMP 0.60
  • MACD
  • AVDL 0.14
  • CMP -0.01
  • Stochastic Oscillator
  • AVDL 61.15
  • CMP 90.67

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: